Delivery Order SPE2DB24D1021-SPE2DB25FEYUZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 0.75 mg/0.5 ml Trulicity pen injectors. The order, valued at $3,794.70, has a completion date of March 7, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp,...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,143.62 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 3 mg/0.5 ml Trulicity pen injectors. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,726.48 delivery order on July 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with an ultimate completion date of July 21, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under an existing contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, and represents a single delivery order fulfilling federal medical procurement...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 ml medical injector pens. The $8,017.58 fixed-price contract has an ultimate completion date of August 5, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of medical commodities to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the medication Trulicity 1.5 mg/0.5 ml pen in 0.5 ml doses. The contract has a ceiling value of $2,902.80 and a completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,366.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Trulicity 0.75 mg/0.5 ml pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,907.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 21, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract involves no set-aside designation and is issued as a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty thousand three hundred five dollars and sixty-seven cents ($30,305.67) to Amerisourcebergen Drug Corporation for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 25 to July 26, 2023. The delivery order was issued under an existing Amerisourcebergen contract vehicle but no further details...
- The Defense Logistics Agency awarded a delivery order valued at $2,148.90 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract, which is not set-aside and uses firm fixed pricing, is scheduled for completion by July 21, 2025, with performance at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement under a larger federal contract vehicle supporting military...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 0.75 mg/0.5 ml Trulicity pens. The order is valued at $16,917.98 and has a completion date of January 30, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is part of a larger indefinite delivery contract...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEYUZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $2,702.70. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, issued on July 18, 2025. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this and similar delivery orders, the company fulfills critical pharmaceutical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, demonstrating its established capability to meet competitive federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/18/25 |